|
|
Volumn 16, Issue 4, 1998, Pages 328-
|
|
UCSF targets cancer IND
a
a
NONE
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
DAUNORUBICIN;
DOXORUBICIN;
IMMUNOGLOBULIN F(AB) FRAGMENT;
IMMUNOLIPOSOME;
MACROGOL;
MONOCLONAL ANTIBODY;
POLYMER;
ACQUIRED IMMUNE DEFICIENCY SYNDROME;
BREAST CANCER;
CANCER CELL;
CANCER CHEMOTHERAPY;
CANCER IMMUNOTHERAPY;
CANCER INHIBITION;
CLINICAL TRIAL;
DRUG DELIVERY SYSTEM;
DRUG FORMULATION;
DRUG TARGETING;
FEMALE;
HUMAN;
HUMAN CELL;
KAPOSI SARCOMA;
NOTE;
ONCOGENE NEU;
PHASE 3 CLINICAL TRIAL;
PRIORITY JOURNAL;
TREATMENT OUTCOME;
WEIGHT REDUCTION;
|
|
EID: 0031981771
PISSN: 10870156
EISSN: None
Source Type: Journal
DOI: 10.1038/nbt0498-328 Document Type: Note |
|
Times cited : (1)
|
|
References (0)
|